Institute of Cancer Research (ICR)

London, United Kingdom

Our next big discovery could be you

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment. We are committed to attracting and developing the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.

We’re searching for the brightest minds in cancer research

Applications for PhDs are invited from talented graduates or final year undergraduates who hold or expect to gain a first or upper second class honours degree or equivalent, or a Masters degree, in a relevant subject. Successful candidates will undertake a four-year research training programme under the guidance of a supervisory team of our world-class researchers, starting in October 2019. Projects and their primary supervisors are listed below. Students receive an annual stipend, currently £21,000 per annum, as well as having fees and project costs paid for the four-year duration. The ICR is a college of the University of London and awards degrees of the University. Below is a list of PhD programmes and projects:

The ICR and Cancer Research UK Centre funded studentships

Professor Clare Isacke
Targeting the activated stroma to limit breast cancer metastasis

Dr Gideon Coster
When DNA becomes its own enemy – formation and resolution of toxic DNA structures during genome repeat replication

Professor Jonathon Pines
What does it take to trigger mitosis?

Dr Jyotl Choudhary
Elucidating the antigenic drivers that underpin immune response in head and neck cancer

Dr Olivia Rossanese
Investigation and characterisation of drug tolerant persister cells that arise in response to CHK1 and MPS1 inhibition

Professor Richard Houlston
Identifying and functionally characterising non-coding drivers for colorectal cancer

Professor Janet Shipley
Role and Therapeutic Potential of Histone Demethylases in Synovial Sarcomas that affect Young Adults

Dr Andreas Wetscherek
Synthetic 4D CT for adaptive MR-guided radiotherapy treatment on an MR-Linac

Dr Matthew Blackledge
Artificial intelligence (Al) for monitoring heterogeneous radiotherapy response in soft-tissue sarcoma imaging

Dr Alessandro Vannlnl
Human TFIIIC, genome topology and cancer

CRUK Children’s Brain Tumour Centre of Excellence funded studentship

Professor Louis Chesler
Regenerating medulloblastoma predisposition using genetically manipulated human stem cells

Sarcoma UK and ICR funded studentship

Dr Paul Huang
Deconstructing the sarcoma matrisome for drug target and biomarker discovery

NIHR Biomedical Research Centre

These studentships fund clinically focussed projects supporting the translational work of the NIHR Biomedical Research Centre at the Royal Marsden and the Institute of Cancer Research:

Dr Chris Bakal
Soft Tissue Sarcoma Diagnosis and Classification from Histopathological Images using Deep Learning

Dr Yinyin Yuan
Deep learning the chemopreventive action of NSAIDs in Barrett’s oesophagus

Dr Paul Huang
Digital proteome mapping of FFPE biopsies for applications in routine practice and clinical trials

Professor Dow-Mu Koh
Developing artificial intelligence and machine learning on MRI of pelvic tumours

Dr Christina Messiou
Developing whole body MRI methods for automated lesion tracking in metastatic melanoma as a tool for assessing heterogeneity and response to immunotherapy

MRC funded industrial CASE (iCASE) programme in Enabling Integrated Drug Discovery

An exciting opportunity to train as a researcher with exposure to and understanding of integrated interdisciplinary drug discovery at the Institute of Cancer Research and in industry.

Professor Ian Collins and Dr Matthew Cheeseman in collaboration with AstraZeneca
Lysine-targeting covalent inhibitors of the molecular chaperone HSP72 and C797S resistant EGFR

Dr Anguraj Sadanandam in collaboration with Merck KGaA
Dissecting heterogeneity in cancer-associated fibroblast (CAF): tumour interactions and personalised targeting in pancreatic ductal adenocarcinoma

The ICR will shortly be advertising joint studentships with Imperial College London – check the website for details

How to apply

Full details about these studentship projects, additional eligibility criteria, and the online application form, are available on our website, at: Applications for all projects should be made online. Please ensure that you read and follow the application instructions very carefully.

Closing date: Monday 19th November 2018. Applicants should be available for interview 28th and 29th January 2019.

Please apply via recruiter’s website.